Astellas Pharma Inc.

Ticker

4503.T

ISIN

JP3942400007

Price

JPY 1,487.00

Change Today

-26.50 / -1.751 %

Price 1 year ago

2,004.07 / -25.801 %

Market Capitalization

3,694,015,283,200.00

52 Week Low

1,446.00

52 Week High

2,255.54

200 Day Moving Average

1,778.76

50-day Moving Average

1,557.78


Price evolution

Yearly Returns


Peers


Peers

Company information

Summary

Astellas Pharma Inc. engages in the manufacture, marketing, import, and export of pharmaceuticals worldwide. It provides XTANDI, an androgen receptor signaling inhibitor for prostate cancer; XOSPATA, a FLT3 inhibitor for adult patients with relapsed or refractory acute myeloid leukemia with a FLT3 mutation-positive; PADCEV, a treatment solution for adult patients with locally advanced or metastatic urothelial cancer; Betanis/Myrbetriq/BETMIGA, a beta-3 adrenergic receptor agonist for the treatment of urgency, urinary frequency, and urge urinary incontinence; Evrenzo, an oral treatment for anemia associated with chronic kidney disease; and Prograf and Advagraf/Graceptor/ASTAGRAF, which are immunosuppressants used to suppress organ rejection following a transplant. The company also offers mirabegron for the treatment of neurogenic detrusor overactivity in pediatric patients; Vesicare for OAB treatment; Eligard to treat prostate cancer; Harnal/Omnic for benign prostatic hyperplasia treatment; and Funguard/MYCAMINE, an antifungal agent. The company has a clinical trial collaboration with Merck & Co., Inc.; CytomX Therapeutics, Inc.; and an agreement with BANDAI NAMCO Entertainment Inc. for the development of smartphone exercise support application. It also has strategic research alliance with Harvard University for the research and development of therapeutics and technologies of mutual interest; research collaboration with Actinium Pharmaceuticals, Inc. to develop targeted radiotherapies using its Antibody Warhead Enabling technology platform, as well as agreement with Zenith Epigenetics Ltd. to evaluate ZEN-3694; and collaboration agreement with Cytokinetics, Incorporated. The company has a strategic collaboration and license agreement with Minovia Therapeutics Ltd. for the research, development, and commercialization of cell therapy programs for diseases caused by mitochondrial dysfunction. Astellas Pharma Inc. was founded in 1923 and is headquartered in Tokyo, Japan.

Sector

Healthcare

Industry

Drug Manufacturers—General

Country

Japan

Exchange

JPX

Earnings Per Share

64.9

P/E Ratio

30.716486

Debt/Equity Ratio

14.615

Beta

0.582175

City

Tokyo

Address

2-5-1, Nihonbashi-Honcho

Zip

103-8411

Ebitda

297,829,007,360.00

Ebitda Margins

0.23

Enterprise to Ebitda

12.39

Enterprise Value

3,690,153,902,080.00

Target Price

2,600.00

Estimated Price

-

Book Value

746.73

Expected Growth

-

Balance sheet

Income statement

Sustainability

Correlation

Company Name Correlation
MYX.AX M PHARMA FPO -0.12
ECILC.IS ECZACIBASI ILAC -0.10
PFE Pfizer, Inc. -0.06
4568.T DAIICHI SANKYO COMPANY LIMITED -0.00
2186.HK LUYE PHARMA 0.02
300006.SZ CHONGQING LUMMY PH 0.03
600572.SS ZHEJIANG CONBA PHARMACEUTICAL C 0.03
NOVN.SW NOVARTIS N 0.07
ABBV AbbVie Inc. 0.08
600713.SS NANJING PHARMACEUTICAL CO LTD 0.09
600867.SS TONGHUA DONGBAO MEDICINES CO LT 0.10
GSK.L GSK PLC 0.15
HZNP Horizon Therapeutics Public Lim 0.17
KLBF.JK Kalbe Farma Tbk. 0.19
4519.T CHUGAI PHARMACEUTICAL CO 0.19
600613.SS SHANGHAI SHENQI PHARM INVEST MA 0.20
SNY Sanofi 0.20
JNJ Johnson & Johnson 0.20
1093.HK CSPC PHARMA 0.21
GILD Gilead Sciences, Inc. 0.22
AMGN Amgen Inc. 0.22
600436.SS ZHANGZHOU PIENTZEHUANG PHARMACE 0.22
BMY Bristol-Myers Squibb Company 0.23
600276.SS JIANGSU HENGRUI MEDICAL CO LTD 0.24
GSK GSK plc 0.24
600771.SS GUANGYUYUAN CHINESE HERBAL MEDI 0.27
AZN Astrazeneca PLC 0.44
LLY Eli Lilly and Company 0.45
MRK Merck & Company, Inc. 0.50

Similar companies

Ticker Name City Country Currency Exchange Beta EV/EBITDA Employees Site
600276.SS JIANGSU HENGRUI MEDICAL CO LTD Lianyungang China CNY SHH 58.73 24491 https://www.hrs.com.cn
KLBF.JK Kalbe Farma Tbk. Jakarta Indonesia IDR JKT 0.50 14.50 12392 https://www.kalbe.co.id
1093.HK CSPC PHARMA Shijiazhuang China HKD HKG 0.67 12.86 24746 https://www.cspc.com.hk
300006.SZ CHONGQING LUMMY PH Chongqing China CNY SHZ 0.83 -32.33 935 https://www.cqlummy.com
PFE Pfizer, Inc. New York United States USD NYQ 0.68 6.88 79000 https://www.pfizer.com
600572.SS ZHEJIANG CONBA PHARMACEUTICAL C Hangzhou China CNY SHH 0.46 10.69 8589 https://www.conbagroup.com
600713.SS NANJING PHARMACEUTICAL CO LTD Nanjing China CNY SHH 0.46 9.37 5062 https://www.njyy.com
600867.SS TONGHUA DONGBAO MEDICINES CO LT Tonghua China CNY SHH 0.24 12.42 https://www.thdb.com
ECILC.IS ECZACIBASI ILAC Istanbul Turkey TRY IST 0.20 71.70 336 https://www.eczacibasi.com.tr/en/eczacibasi-gruop/companies/other-products-and-services
GSK.L GSK PLC Brentford United Kingdom GBp LSE 0.32 6.22 90096 https://www.gsk.com
MRK Merck & Company, Inc. Kenilworth United States USD NYQ 0.36 10.37 67000 https://www.merck.com
BMY Bristol-Myers Squibb Company New York United States USD NYQ 0.44 8.87 32200 https://www.bms.com
600771.SS GUANGYUYUAN CHINESE HERBAL MEDI Xi'an China CNY SHH 0.55 -48.11 1900 https://www.guangyuyuan.com
GILD Gilead Sciences, Inc. Foster City United States USD NMS 0.39 7.19 14400 https://www.gilead.com
JNJ Johnson & Johnson New Brunswick United States USD NYQ 0.57 14.45 141700 https://www.jnj.com
GSK GSK plc Brentford United Kingdom USD NYQ 0.18 8.08 90096 https://www.gsk.com
AZN Astrazeneca PLC Cambridge United Kingdom USD NMS 0.12 18.55 83100 https://www.astrazeneca.com
ABBV AbbVie Inc. North Chicago United States USD NYQ 0.75 11.46 50000 https://www.abbvie.com
2186.HK LUYE PHARMA Yantai China HKD HKG 0.75 14.06 4845 https://www.luye.cn
600613.SS SHANGHAI SHENQI PHARM INVEST MA Shanghai China CNY SHH 0.36 22.96 1371 https://www.gzsq.com
MYX.AX M PHARMA FPO Salisbury South Australia AUD ASX 1.09 27.98 https://www.maynepharma.com
4568.T DAIICHI SANKYO COMPANY LIMITED Tokyo Japan JPY JPX 52.12 16458 https://www.daiichisankyo.com
4503.T ASTELLAS PHARMA Tokyo Japan JPY JPX 0.58 12.39 14522 https://www.astellas.com
NOVN.SW NOVARTIS N Basel Switzerland CHF EBS 0.50 10.30 108000 https://www.novartis.com
SNY Sanofi Paris France USD NMS 0.36 9.75 95442 https://www.sanofi.com
HZNP Horizon Therapeutics Public Lim Dublin Ireland USD NMS 1.16 20.67 1940 https://www.horizontherapeutics.com
LLY Eli Lilly and Company Indianapolis United States USD NYQ 0.37 29.00 35000 https://www.lilly.com
AMGN Amgen Inc. Thousand Oaks United States USD NMS 0.58 12.61 24200 https://www.amgen.com
4519.T CHUGAI PHARMACEUTICAL CO Tokyo Japan JPY JPX 0.64 9.60 7664 https://www.chugai-pharm.co.jp
600436.SS ZHANGZHOU PIENTZEHUANG PHARMACE Zhangzhou China CNY SHH 0.78 57.53 2591 https://www.zzpzh.com.cn
BAYN.DE BAYER AG Leverkusen Germany EUR GER 1.16 13.66 101914 https://www.bayer.com
AZN.L ASTRAZENECA PLC ORD SHS $0.25 Cambridge United Kingdom GBp LSE 0.10 15.96 83100 https://www.astrazeneca.com
300357.SZ ZHEJIANG WOLWO BIO Huzhou China CNY SHZ 0.40 56.57 1488 https://www.wolwobiotech.com
SAN.PA SANOFI Paris France EUR PAR 0.36 9.86 95442 https://www.sanofi.com
NVS Novartis AG Basel Switzerland USD NYQ 0.49 10.62 108000 https://www.novartis.com
0P6S.IL BAYER AG Leverkusen Germany EUR IOB 1.15 9.51 100753 https://www.bayer.com
CIPLA.NS CIPLA LTD Mumbai India INR NSI 17.91 https://www.cipla.com
4528.T ONO PHARMACEUTICAL CO Osaka Japan JPY JPX 0.33 13.40 3687 https://www.ono-pharma.com
4536.T SANTEN PHARMACEUTICAL CO Osaka Japan JPY JPX 0.37 7.05 4315 https://www.santen.com
OGN Organon & Co. Jersey City United States USD NYQ 7.83 9300 https://www.organon.com

Funds


Mutual Fund Holders

Social

Dividends

Ratings

News

Earnings

SEC Filings

Options

Indicators

Glossary
Momentum
A technical indicator that measures the rate of change in price movements over a specific period. It indicates the strength or weakness of a price trend.
Assessment: A positive momentum value generally indicates a good trend, while a negative value suggests a weak or downward trend.
Inertia
In trading, inertia refers to the tendency of prices to continue moving in their current direction. It suggests that an asset's price will likely maintain its current trend.
Assessment: A higher inertia value is generally considered good, as it indicates a strong and sustained price trend.
Relative Strength Index (RSI)
A momentum oscillator that measures the speed and change of price movements. It helps identify overbought or oversold conditions in an asset.
Assessment: An RSI value above 70 is typically considered overbought and may suggest a potential reversal or correction. Conversely, an RSI value below 30 is often considered oversold, indicating a possible upward price correction.
Fibonacci's Weighted Moving Average
A technical indicator that assigns different weights to recent data points, giving more significance to recent prices. It helps smooth out price fluctuations and identify trend reversals.
Assessment: The interpretation of the Fibonacci's Weighted Moving Average value depends on its comparison to other moving averages or trendlines. A value above 50 may indicate an uptrend, while a value below 50 may suggest a downtrend.
Williams %R
A momentum indicator that measures overbought or oversold conditions in an asset. It shows the relationship of the current closing price to the high-low range over a specified period.
Assessment: Williams %R values above -20 are typically considered overbought and may indicate a potential price reversal. Values below -80 are often viewed as oversold, suggesting a potential price bounce.
Relative Volatility Index (RVI)
A technical indicator that measures the volatility of a security by comparing the magnitude of recent price movements to the magnitude of average price changes. It helps identify periods of high or low volatility.
Assessment: A higher RVI value suggests higher volatility, which can provide trading opportunities but also carries increased risk.
Commodity Channel Index (CCI)
A versatile indicator that measures the current price level relative to an average price level over a given period. It helps identify overbought or oversold conditions and potential trend reversals.
Assessment: CCI values above 100 are often considered overbought, indicating a potential price correction or reversal. Values below -100 are typically viewed as oversold, suggesting a potential price rebound.